Teva Pharmaceutical Industries Limited is believed to be in preliminary discussions to buy Handok Pharmaceuticals Co., Ltd., according to reports in JoongAng Dail. Young-Jin Kim, Chief Executive Officer and Chairman of Handok, holds 46.8% of Hando and IMM Private Equity owns 30% of Handok.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.88 USD | +1.75% | +0.60% | +61.69% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.69% | 19.12B | |
+37.74% | 723B | |
+32.22% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+16.60% | 244B | |
+9.77% | 208B | |
-5.15% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Teva Reportedly In Talks To Acquire Handok Pharmaceuticals